Embecta EBITDA 2021-2024 | EMBC
Embecta ebitda from 2021 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Embecta Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $216 |
| 2023 | $261 |
| 2022 | $345 |
| 2021 | $530 |
| 2020 | $525 |
| Embecta Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-12-31 | $43 |
| 2024-09-30 | $40 |
| 2024-06-30 | $69 |
| 2024-03-31 | $51 |
| 2023-12-31 | $56 |
| 2023-09-30 | $37 |
| 2023-06-30 | $61 |
| 2023-03-31 | $65 |
| 2022-12-31 | $98 |
| 2022-09-30 | $6 |
| 2022-06-30 | $108 |
| 2022-03-31 | $106 |
| 2021-12-31 | $125 |
| 2021-09-30 | $126 |
| 2021-06-30 | $134 |
| 2021-03-31 | $137 |
| 2020-12-31 | $133 |
| 2020-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.740B | $1.123B |
| Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J. | |||